BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that on January 26, 2023, Spectrum’s ...
BOSTON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals (RYTM), Inc. , a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare ...
BOSTON, April 06, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results